Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 9/20 | 0.70 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | TLR4 | O00206 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Genipin SCHEMBL22557817 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL25807077 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL20083921 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL5075862 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL7478142 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL34249 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL9609096 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL13526030 | 1.00 | PTPN1 (0.70) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL5134206 | 0.99 | PTPN1 (0.69) | PTPN1MEN1KMT2ATLR4 | |
| Genipin SCHEMBL19356583 | 0.97 | PTPN1 (0.71) | PTPN1MEN1KMT2ATLR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250143865-A1 | METHODS AND SYSTEMS FOR PREVENTING OR REDUCING STENOSIS IN A SUBJECT RECEIVING A GRAFT | MASSACHUSETTS GEN HOSPITAL (US) | 2025-05-08 | — | — | US | disclosed |
| US-12208001-B2 | Methods and systems for preventing or reducing stenosis in a subject receiving a graft | THE GENERAL HOSPITAL CORPORATION (US) | 2025-01-28 | — | — | US | disclosed |
| US-20220249221-A1 | METHODS FOR TISSUE PASSIVATION | THE GENERAL HOSPITAL CORPORATION (US) | 2022-08-11 | — | — | US | disclosed |
| US-11337792-B2 | Methods for tissue passivation | THE GENERAL HOSPITAL CORPORATION (US) | 2022-05-24 | — | — | US | disclosed |
| US-10478284-B2 | Methods for tissue passivation | THE GENERAL HOSPITAL CORPORATION (US) | 2019-11-19 | — | — | US | disclosed |
| US-20150134049-A1 | Methods for Tissue Passivation | THE GENERAL HOSPITAL CORPORATION | 2015-05-14 | — | — | US | disclosed |